Norman D. Lafrance's Net Worth
-$10.9 Thousand
Who is Norman D. Lafrance?
Norman D. Lafrance does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Molecular Insight Pharmaceuticals, Inc., and PLUS THERAPEUTICS, INC..
SEC CIK
Norman D. Lafrance's CIK is 0001397768
Past Insider Trading and Trends
2007 was Norman D. Lafrance's most active year for acquiring shares with 5 total transactions. Norman D. Lafrance's most active month to acquire stocks was the month of October. 2009 was Norman D. Lafrance's most active year for disposing of shares, totalling 1 transactions. Norman D. Lafrance's most active month to dispose stocks was the month of April. 2007 saw Norman D. Lafrance paying a total of $33,647.00 for 79,000 shares, this is the most they've acquired in one year. In 2009 Norman D. Lafrance cashed out on 6,093 shares for a total of $22,909.68, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Molecular Insight Pharmaceuticals, Inc. No price found
Sr. VP Clinical Dev and CMO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -26.78% | -6.09K |
$3.76 | -$22,909.68 | 16.66K |
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
| +468.75% | 18.75K |
$0.01 | $187.50 | 22.75K |
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
| +100.00% | 2K |
$8.78 | $17,557.00 | 4K |
Nov 30
| |||
Form 4
|
∞
| 2K |
$8.05 | $16,090.00 | 2K |
Nov 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PLUS THERAPEUTICS, INC. (PSTV) Snapshot price: $2.15
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |